{
  "id": "47_ref_0",
  "query": "背景：拟以25 nt Morpholino靶向目标外显子5'端pre-mRNA以诱导外显子跳跃，纠正阅读框。两情景的寡核苷酸长度相同、结合效率相同，均可诱导外显子跳跃；两情景的治疗尝试未达预期（therapy_success=false）。相关数据库（U1/U2 5' splice site、80S翻译复合体、ESE于外显子47近5'端）检索均未返回可用记录（报错）。\n已知：\n- 情景A（患者A）：已缺失外显子[45,46]；original total_deleted_bases=330，original in_frame=true；如再跳跃外显子47，则therapy total_deleted_bases=480，therapy in_frame=true。跳跃后拼接假设：exon44–exon48；机制图ID=mech_A。\n- 情景B（患者B）：已缺失外显子[48,49,50]；original total_deleted_bases=450，original in_frame=true；如再跳跃外显子51，则therapy total_deleted_bases=600，therapy in_frame=true。跳跃后拼接假设：exon47–exon52；机制图ID=mech_B。\n- 折叠重复域连续性判定规则：每个外显子≈1条α螺旋，三条为一组；跨越的缺失外显子数为3的倍数→“连续性保持”，否则→“可能破坏相位”。\n- 情景A设计需评估ESE_overlap_risk。定义：覆盖窗口相对目标外显子起始位点E+1为[E−x..E+y]且总长度=25 nt，ESE_overlap_risk=窗口内位于外显子侧的碱基数/25；目标是在阻断5'端剪接位点的同时尽量降低该风险。\n任务：\n1) 分别给出情景A与B在“原突变”和“跳跃后”的mod3_shift（total_deleted_bases mod 3），并给出frame_restored（若原本即为in-frame，则视为保持true）。\n2) 分别给出两情景的predicted_junction与机制图ID。\n3) 依据给定规则，判断上述拼接是否保持折叠重复域连续性。\n4) 情景A报告ESE_overlap_risk，并给出推荐的Morpholino覆盖窗口表达形式（长度=25 nt），使其跨越外显子—内含子边界且尽量降低ESE_overlap_risk。\n5) 比较两情景的off_target_risk（在长度与结合效率相同、无序列差异信息时判为相当），并在therapy_success=false前提下给出较优方案与理由。\n6) 在以下四个结构中判定哪一个不参与该治疗机制（Morpholino介导的前体mRNA剪接调控），并给出论证，需引用“数据库检索均未返回记录（报错）”与本题第(3)步及“验证矩阵”的机制证据；同时提交验证矩阵：对下列四个结构给出参与度分数（0~1）与简要理由（跨情景一致）：\n   a) pre-mRNA目标外显子5'端剪接位点（受体/供体边界）\n   b) spliceosome_U1_U2_5prime_splice_site\n   c) ESE_SRSF_family_sites_exon47_5prime\n   d) ribosome_80S_translation_complex\n说明：核酸长度以nt计；除(6)中的参与度分数外，其余结果以符号表达式给出。",
  "query_data": {
    "id": "47_ref_0",
    "original_id": 47,
    "refined_index": 0,
    "question": "背景：拟以25 nt Morpholino靶向目标外显子5'端pre-mRNA以诱导外显子跳跃，纠正阅读框。两情景的寡核苷酸长度相同、结合效率相同，均可诱导外显子跳跃；两情景的治疗尝试未达预期（therapy_success=false）。相关数据库（U1/U2 5' splice site、80S翻译复合体、ESE于外显子47近5'端）检索均未返回可用记录（报错）。\n已知：\n- 情景A（患者A）：已缺失外显子[45,46]；original total_deleted_bases=330，original in_frame=true；如再跳跃外显子47，则therapy total_deleted_bases=480，therapy in_frame=true。跳跃后拼接假设：exon44–exon48；机制图ID=mech_A。\n- 情景B（患者B）：已缺失外显子[48,49,50]；original total_deleted_bases=450，original in_frame=true；如再跳跃外显子51，则therapy total_deleted_bases=600，therapy in_frame=true。跳跃后拼接假设：exon47–exon52；机制图ID=mech_B。\n- 折叠重复域连续性判定规则：每个外显子≈1条α螺旋，三条为一组；跨越的缺失外显子数为3的倍数→“连续性保持”，否则→“可能破坏相位”。\n- 情景A设计需评估ESE_overlap_risk。定义：覆盖窗口相对目标外显子起始位点E+1为[E−x..E+y]且总长度=25 nt，ESE_overlap_risk=窗口内位于外显子侧的碱基数/25；目标是在阻断5'端剪接位点的同时尽量降低该风险。\n任务：\n1) 分别给出情景A与B在“原突变”和“跳跃后”的mod3_shift（total_deleted_bases mod 3），并给出frame_restored（若原本即为in-frame，则视为保持true）。\n2) 分别给出两情景的predicted_junction与机制图ID。\n3) 依据给定规则，判断上述拼接是否保持折叠重复域连续性。\n4) 情景A报告ESE_overlap_risk，并给出推荐的Morpholino覆盖窗口表达形式（长度=25 nt），使其跨越外显子—内含子边界且尽量降低ESE_overlap_risk。\n5) 比较两情景的off_target_risk（在长度与结合效率相同、无序列差异信息时判为相当），并在therapy_success=false前提下给出较优方案与理由。\n6) 在以下四个结构中判定哪一个不参与该治疗机制（Morpholino介导的前体mRNA剪接调控），并给出论证，需引用“数据库检索均未返回记录（报错）”与本题第(3)步及“验证矩阵”的机制证据；同时提交验证矩阵：对下列四个结构给出参与度分数（0~1）与简要理由（跨情景一致）：\n   a) pre-mRNA目标外显子5'端剪接位点（受体/供体边界）\n   b) spliceosome_U1_U2_5prime_splice_site\n   c) ESE_SRSF_family_sites_exon47_5prime\n   d) ribosome_80S_translation_complex\n说明：核酸长度以nt计；除(6)中的参与度分数外，其余结果以符号表达式给出。",
    "answer": "{'(1)': {'A': {'mod3_shift_original': '330 mod 3', 'mod3_shift_therapy': '480 mod 3', 'frame_restored': 'true'}, 'B': {'mod3_shift_original': '450 mod 3', 'mod3_shift_therapy': '600 mod 3', 'frame_restored': 'true'}}, '(2)': {'A': {'predicted_junction': 'exon44–exon48', 'mechanism_fig_id': 'mech_A'}, 'B': {'predicted_junction': 'exon47–exon52', 'mechanism_fig_id': 'mech_B'}}, '(3)': {'A_repeat_domain_continuity': '保持（跨越缺失外显子数为3的倍数）', 'B_repeat_domain_continuity': '可能破坏（跨越缺失外显子数非3的倍数）'}, '(4)': {'ESE_overlap_risk_A': 'm/25（m为窗口内位于外显子侧的碱基数）', 'recommended_window_A': '[E−(25−m)..E+(m−1)]，取m为满足跨越边界且可阻断剪接位点的最小值（m≥1）以最小化m/25'}, '(5)': {'off_target_risk_A_vs_B': '相当（长度与结合效率相同，且无序列差异信息）', 'preferred_plan': '不追加外显子跳跃', 'justification': '在therapy_success=false且两情景原本均为in-frame的前提下，继续跳跃不改善阅读框且增加潜在风险；若必须二选一，选A因折叠重复域连续性判断更优'}, '(6)': {'non_involved_structure': 'ribosome_80S_translation_complex', 'reason': '该机制发生于前体mRNA剪接阶段；数据库检索对相关条目未返回记录（报错）不影响基于机制的判定；第(3)步与验证矩阵均指向剪接层面证据，翻译复合体不参与', 'validation_matrix': [{'structure': \"pre-mRNA目标外显子5'端剪接位点\", 'participation_score': 1.0, 'rationale': '需跨越外显子—内含子边界以阻断装配，跨情景一致'}, {'structure': 'spliceosome_U1_U2_5prime_splice_site', 'participation_score': 1.0, 'rationale': '作用机理为干扰U1/U2相关识别实现外显子跳跃；尽管数据库检索报错，机制证据充分'}, {'structure': 'ESE_SRSF_family_sites_exon47_5prime', 'participation_score': 0.7, 'rationale': 'ESE影响外显子选择；(4)中通过最小化m降低ESE_overlap_risk，提示其为需权衡的参与因子'}, {'structure': 'ribosome_80S_translation_complex', 'participation_score': 0.0, 'rationale': '翻译阶段结构，不参与前体mRNA剪接调控；数据库检索报错且无机制需求'}]}}",
    "metadata": {
      "subject": "Life Science",
      "topic": "Cell Biology",
      "image_path": null,
      "solution_steps": [],
      "tool_expected": [
        "analyze_dmd_mutation_therapy",
        "identify_non_involved_structures",
        "visualize_exon_skipping_mechanism",
        "query_rna_structure_involvement"
      ],
      "golden_answer": [
        {
          "(1)": {
            "A": {
              "mod3_shift_original": "330 mod 3",
              "mod3_shift_therapy": "480 mod 3",
              "frame_restored": "true"
            },
            "B": {
              "mod3_shift_original": "450 mod 3",
              "mod3_shift_therapy": "600 mod 3",
              "frame_restored": "true"
            }
          },
          "(2)": {
            "A": {
              "predicted_junction": "exon44–exon48",
              "mechanism_fig_id": "mech_A"
            },
            "B": {
              "predicted_junction": "exon47–exon52",
              "mechanism_fig_id": "mech_B"
            }
          },
          "(3)": {
            "A_repeat_domain_continuity": "保持（跨越缺失外显子数为3的倍数）",
            "B_repeat_domain_continuity": "可能破坏（跨越缺失外显子数非3的倍数）"
          },
          "(4)": {
            "ESE_overlap_risk_A": "m/25（m为窗口内位于外显子侧的碱基数）",
            "recommended_window_A": "[E−(25−m)..E+(m−1)]，取m为满足跨越边界且可阻断剪接位点的最小值（m≥1）以最小化m/25"
          },
          "(5)": {
            "off_target_risk_A_vs_B": "相当（长度与结合效率相同，且无序列差异信息）",
            "preferred_plan": "不追加外显子跳跃",
            "justification": "在therapy_success=false且两情景原本均为in-frame的前提下，继续跳跃不改善阅读框且增加潜在风险；若必须二选一，选A因折叠重复域连续性判断更优"
          },
          "(6)": {
            "non_involved_structure": "ribosome_80S_translation_complex",
            "reason": "该机制发生于前体mRNA剪接阶段；数据库检索对相关条目未返回记录（报错）不影响基于机制的判定；第(3)步与验证矩阵均指向剪接层面证据，翻译复合体不参与",
            "validation_matrix": [
              {
                "structure": "pre-mRNA目标外显子5'端剪接位点",
                "participation_score": 1.0,
                "rationale": "需跨越外显子—内含子边界以阻断装配，跨情景一致"
              },
              {
                "structure": "spliceosome_U1_U2_5prime_splice_site",
                "participation_score": 1.0,
                "rationale": "作用机理为干扰U1/U2相关识别实现外显子跳跃；尽管数据库检索报错，机制证据充分"
              },
              {
                "structure": "ESE_SRSF_family_sites_exon47_5prime",
                "participation_score": 0.7,
                "rationale": "ESE影响外显子选择；(4)中通过最小化m降低ESE_overlap_risk，提示其为需权衡的参与因子"
              },
              {
                "structure": "ribosome_80S_translation_complex",
                "participation_score": 0.0,
                "rationale": "翻译阶段结构，不参与前体mRNA剪接调控；数据库检索报错且无机制需求"
              }
            ]
          }
        }
      ],
      "original_question_id": "47",
      "test_type": "refined",
      "dataset_key": "merged_questions_augmented",
      "trace_root": "/Users/yangyajie/Desktop/code/Toolkit/tracetoanalyze/traces",
      "_dataset_filename": "refine_merged_single_questions.json"
    },
    "usage_tool_protocol": [
      {
        "type": "function",
        "function": {
          "name": "query_rna_structure_involvement",
          "description": "查询RNA结构在Morpholino治疗中的参与情况",
          "strict": true,
          "parameters": {
            "type": "object",
            "properties": {
              "structure_name": {
                "type": "string",
                "description": "RNA结构名称"
              }
            },
            "required": [
              "structure_name"
            ]
          }
        },
        "additionalProperties": {
          "function_path": "./tools/molecular_biology_toolkit_claude_5.py",
          "resolved_file_path": "toolkits/life_science/cell_biology/molecular_biology_toolkit_claude_5.py",
          "resolved_dir": "toolkits/life_science/cell_biology"
        }
      },
      {
        "type": "function",
        "function": {
          "name": "analyze_dmd_mutation_therapy",
          "description": "分析DMD突变和外显子跳跃治疗策略",
          "strict": true,
          "parameters": {
            "type": "object",
            "properties": {
              "deleted_exons": {
                "type": "array",
                "items": {
                  "type": "integer"
                },
                "description": "缺失的外显子编号列表"
              },
              "target_skip_exon": {
                "type": "integer",
                "description": "目标跳跃的外显子编号"
              }
            },
            "required": [
              "deleted_exons",
              "target_skip_exon"
            ]
          }
        },
        "additionalProperties": {
          "function_path": "./tools/molecular_biology_toolkit_claude_5.py"
        }
      },
      {
        "type": "function",
        "function": {
          "name": "identify_non_involved_structures",
          "description": "结合数据库识别不参与Morpholino治疗的RNA结构",
          "strict": true,
          "parameters": {
            "type": "object",
            "properties": {},
            "required": []
          }
        },
        "additionalProperties": {
          "function_path": "./tools/molecular_biology_toolkit_claude_5.py"
        }
      },
      {
        "type": "function",
        "function": {
          "name": "visualize_exon_skipping_mechanism",
          "description": "可视化外显子跳跃机制",
          "strict": true,
          "parameters": {
            "type": "object",
            "properties": {
              "deleted_exons": {
                "type": "array",
                "items": {
                  "type": "integer"
                },
                "description": "缺失的外显子编号列表"
              },
              "target_exon": {
                "type": "integer",
                "description": "目标外显子编号"
              }
            },
            "required": [
              "deleted_exons",
              "target_exon"
            ]
          }
        },
        "additionalProperties": {
          "function_path": "./tools/molecular_biology_toolkit_claude_5.py"
        }
      }
    ],
    "refined_version_data": {
      "refined_question": "背景：拟以25 nt Morpholino靶向目标外显子5'端pre-mRNA以诱导外显子跳跃，纠正阅读框。两情景的寡核苷酸长度相同、结合效率相同，均可诱导外显子跳跃；两情景的治疗尝试未达预期（therapy_success=false）。相关数据库（U1/U2 5' splice site、80S翻译复合体、ESE于外显子47近5'端）检索均未返回可用记录（报错）。\n已知：\n- 情景A（患者A）：已缺失外显子[45,46]；original total_deleted_bases=330，original in_frame=true；如再跳跃外显子47，则therapy total_deleted_bases=480，therapy in_frame=true。跳跃后拼接假设：exon44–exon48；机制图ID=mech_A。\n- 情景B（患者B）：已缺失外显子[48,49,50]；original total_deleted_bases=450，original in_frame=true；如再跳跃外显子51，则therapy total_deleted_bases=600，therapy in_frame=true。跳跃后拼接假设：exon47–exon52；机制图ID=mech_B。\n- 折叠重复域连续性判定规则：每个外显子≈1条α螺旋，三条为一组；跨越的缺失外显子数为3的倍数→“连续性保持”，否则→“可能破坏相位”。\n- 情景A设计需评估ESE_overlap_risk。定义：覆盖窗口相对目标外显子起始位点E+1为[E−x..E+y]且总长度=25 nt，ESE_overlap_risk=窗口内位于外显子侧的碱基数/25；目标是在阻断5'端剪接位点的同时尽量降低该风险。\n任务：\n1) 分别给出情景A与B在“原突变”和“跳跃后”的mod3_shift（total_deleted_bases mod 3），并给出frame_restored（若原本即为in-frame，则视为保持true）。\n2) 分别给出两情景的predicted_junction与机制图ID。\n3) 依据给定规则，判断上述拼接是否保持折叠重复域连续性。\n4) 情景A报告ESE_overlap_risk，并给出推荐的Morpholino覆盖窗口表达形式（长度=25 nt），使其跨越外显子—内含子边界且尽量降低ESE_overlap_risk。\n5) 比较两情景的off_target_risk（在长度与结合效率相同、无序列差异信息时判为相当），并在therapy_success=false前提下给出较优方案与理由。\n6) 在以下四个结构中判定哪一个不参与该治疗机制（Morpholino介导的前体mRNA剪接调控），并给出论证，需引用“数据库检索均未返回记录（报错）”与本题第(3)步及“验证矩阵”的机制证据；同时提交验证矩阵：对下列四个结构给出参与度分数（0~1）与简要理由（跨情景一致）：\n   a) pre-mRNA目标外显子5'端剪接位点（受体/供体边界）\n   b) spliceosome_U1_U2_5prime_splice_site\n   c) ESE_SRSF_family_sites_exon47_5prime\n   d) ribosome_80S_translation_complex\n说明：核酸长度以nt计；除(6)中的参与度分数外，其余结果以符号表达式给出。",
      "final_answer": {
        "(1)": {
          "A": {
            "mod3_shift_original": "330 mod 3",
            "mod3_shift_therapy": "480 mod 3",
            "frame_restored": "true"
          },
          "B": {
            "mod3_shift_original": "450 mod 3",
            "mod3_shift_therapy": "600 mod 3",
            "frame_restored": "true"
          }
        },
        "(2)": {
          "A": {
            "predicted_junction": "exon44–exon48",
            "mechanism_fig_id": "mech_A"
          },
          "B": {
            "predicted_junction": "exon47–exon52",
            "mechanism_fig_id": "mech_B"
          }
        },
        "(3)": {
          "A_repeat_domain_continuity": "保持（跨越缺失外显子数为3的倍数）",
          "B_repeat_domain_continuity": "可能破坏（跨越缺失外显子数非3的倍数）"
        },
        "(4)": {
          "ESE_overlap_risk_A": "m/25（m为窗口内位于外显子侧的碱基数）",
          "recommended_window_A": "[E−(25−m)..E+(m−1)]，取m为满足跨越边界且可阻断剪接位点的最小值（m≥1）以最小化m/25"
        },
        "(5)": {
          "off_target_risk_A_vs_B": "相当（长度与结合效率相同，且无序列差异信息）",
          "preferred_plan": "不追加外显子跳跃",
          "justification": "在therapy_success=false且两情景原本均为in-frame的前提下，继续跳跃不改善阅读框且增加潜在风险；若必须二选一，选A因折叠重复域连续性判断更优"
        },
        "(6)": {
          "non_involved_structure": "ribosome_80S_translation_complex",
          "reason": "该机制发生于前体mRNA剪接阶段；数据库检索对相关条目未返回记录（报错）不影响基于机制的判定；第(3)步与验证矩阵均指向剪接层面证据，翻译复合体不参与",
          "validation_matrix": [
            {
              "structure": "pre-mRNA目标外显子5'端剪接位点",
              "participation_score": 1.0,
              "rationale": "需跨越外显子—内含子边界以阻断装配，跨情景一致"
            },
            {
              "structure": "spliceosome_U1_U2_5prime_splice_site",
              "participation_score": 1.0,
              "rationale": "作用机理为干扰U1/U2相关识别实现外显子跳跃；尽管数据库检索报错，机制证据充分"
            },
            {
              "structure": "ESE_SRSF_family_sites_exon47_5prime",
              "participation_score": 0.7,
              "rationale": "ESE影响外显子选择；(4)中通过最小化m降低ESE_overlap_risk，提示其为需权衡的参与因子"
            },
            {
              "structure": "ribosome_80S_translation_complex",
              "participation_score": 0.0,
              "rationale": "翻译阶段结构，不参与前体mRNA剪接调控；数据库检索报错且无机制需求"
            }
          ]
        }
      }
    },
    "metadata_summary": {
      "subject": "Life Science",
      "topic": "Cell Biology",
      "test_type": "refined",
      "original_question_id": "47",
      "subject_topic_key": "Life Science::Cell Biology"
    }
  },
  "model": "glm-4.6v",
  "use_tools": true,
  "mode": "tool_mode",
  "rounds": 7,
  "messages": [
    {
      "role": "system",
      "content": "你是一个顶尖的 AI 科学助手，你的任务是解决来自物理、化学、生物等领域的复杂、多模态、多步骤问题。\n\n# 任务指令：两阶段方法\n\n你必须严格遵循以下两个阶段来回答问题：\n\n**阶段 1: 规划 (Planning)**\n在开始执行任何操作之前，你必须首先生成一个高阶的、分步骤的“计划”。这个计划应该概述你打算如何分解问题、使用哪些工具、以及工具之间的依赖关系。\n\n**阶段 2: 执行 (Execution)**\n在提交计划后，你将开始逐一执行。你必须严格遵循以下的 \"ReAct\" 格式 (Thought, Action, Observation)，直到你得出最终答案。\n\n---\n\n**输出格式规范**\n\n**[阶段 1: 规划]**\nPlan:\n\n1. [你的计划步骤 1，例如：分析输入图像中的分子结构]\n2. [你的计划步骤 2，例如：使用 `analyze_molecule` 工具获取 SMILES]\n3. [你的计划步骤 3，例如：将 SMILES 传入 `calculate_properties` 工具]\n4. ...\n5. [你的计划步骤 N，例如：总结所有属性并回答问题]\n\n**[阶段 2: 执行]**\nThought: [描述你当前的思考，你正处于计划的第几步，以及你为什么需要调用这个特定的工具。]\nAction: 请你在这一步发出工具调用\n\n[在你提交 Action 后，你将收到一个 Observation]\n\nObservation: [这里将由评测系统插入工具的返回结果]\n\n[然后你重复这个循环]\n\nThought: [基于上一步的 Observation，你的新思考。]\nAction: 请你在这一步发出工具调用\n\n...\n[当你收集到所有信息并准备好回答时]\n\nThought: [我已收集到所有必要信息，现在可以生成最终答案了。]\nFinal Answer: [这里是对原始问题的最终、完整回答。]"
    },
    {
      "role": "user",
      "content": "背景：拟以25 nt Morpholino靶向目标外显子5'端pre-mRNA以诱导外显子跳跃，纠正阅读框。两情景的寡核苷酸长度相同、结合效率相同，均可诱导外显子跳跃；两情景的治疗尝试未达预期（therapy_success=false）。相关数据库（U1/U2 5' splice site、80S翻译复合体、ESE于外显子47近5'端）检索均未返回可用记录（报错）。\n已知：\n- 情景A（患者A）：已缺失外显子[45,46]；original total_deleted_bases=330，original in_frame=true；如再跳跃外显子47，则therapy total_deleted_bases=480，therapy in_frame=true。跳跃后拼接假设：exon44–exon48；机制图ID=mech_A。\n- 情景B（患者B）：已缺失外显子[48,49,50]；original total_deleted_bases=450，original in_frame=true；如再跳跃外显子51，则therapy total_deleted_bases=600，therapy in_frame=true。跳跃后拼接假设：exon47–exon52；机制图ID=mech_B。\n- 折叠重复域连续性判定规则：每个外显子≈1条α螺旋，三条为一组；跨越的缺失外显子数为3的倍数→“连续性保持”，否则→“可能破坏相位”。\n- 情景A设计需评估ESE_overlap_risk。定义：覆盖窗口相对目标外显子起始位点E+1为[E−x..E+y]且总长度=25 nt，ESE_overlap_risk=窗口内位于外显子侧的碱基数/25；目标是在阻断5'端剪接位点的同时尽量降低该风险。\n任务：\n1) 分别给出情景A与B在“原突变”和“跳跃后”的mod3_shift（total_deleted_bases mod 3），并给出frame_restored（若原本即为in-frame，则视为保持true）。\n2) 分别给出两情景的predicted_junction与机制图ID。\n3) 依据给定规则，判断上述拼接是否保持折叠重复域连续性。\n4) 情景A报告ESE_overlap_risk，并给出推荐的Morpholino覆盖窗口表达形式（长度=25 nt），使其跨越外显子—内含子边界且尽量降低ESE_overlap_risk。\n5) 比较两情景的off_target_risk（在长度与结合效率相同、无序列差异信息时判为相当），并在therapy_success=false前提下给出较优方案与理由。\n6) 在以下四个结构中判定哪一个不参与该治疗机制（Morpholino介导的前体mRNA剪接调控），并给出论证，需引用“数据库检索均未返回记录（报错）”与本题第(3)步及“验证矩阵”的机制证据；同时提交验证矩阵：对下列四个结构给出参与度分数（0~1）与简要理由（跨情景一致）：\n   a) pre-mRNA目标外显子5'端剪接位点（受体/供体边界）\n   b) spliceosome_U1_U2_5prime_splice_site\n   c) ESE_SRSF_family_sites_exon47_5prime\n   d) ribosome_80S_translation_complex\n说明：核酸长度以nt计；除(6)中的参与度分数外，其余结果以符号表达式给出。\nYou should strictly respond in this exact format and answer the question in its original language:\nexample:###Answer###\n$\\boxed{}$"
    },
    {
      "role": "assistant",
      "content": "\n###Answer###\n[阶段 1: 规划]\nPlan:\n\n1. 计算情景A和B在\"原突变\"和\"跳跃后\"的mod3_shift（total_deleted_bases mod 3）\n2. 确定两情景的predicted_junction与机制图ID\n3. 依据折叠重复域连续性判定规则，判断拼接是否保持连续性\n4. 计算情景A的ESE_overlap_risk，并推荐Morpholino覆盖窗口\n5. 比较两情景的off_target_risk，在therapy_success=false前提下给出较优方案\n6. 判定四个结构中哪一个不参与治疗机制，并提交验证矩阵\n\n[阶段 2: 执行]\nThought: 我开始执行计划。首先计算情景A和B的mod3_shift。对于情景A，原突变total_deleted_bases=330，跳跃后=480；对于情景B，原突变total_deleted_bases=450，跳跃后=600。我需要计算这些值除以3的余数。\nAction: analyze_dmd_mutation_therapy\n<arg_key>deleted_exons</arg_key>\n<arg_value>[45, 46]</arg_value>\n<arg_key>target_skip_exon</arg_key>\n<arg_value>47</arg_value>\n</tool_call>"
    },
    {
      "role": "tool",
      "content": {
        "result": {
          "original_mutation": {
            "deleted_exons": [
              45,
              46
            ],
            "total_deleted_bases": 330,
            "frame_shift": 0,
            "in_frame": true,
            "out_of_frame": false
          },
          "therapy_outcome": {
            "deleted_exons": [
              45,
              46,
              47
            ],
            "total_deleted_bases": 480,
            "frame_shift": 0,
            "in_frame": true,
            "out_of_frame": false
          },
          "morpholino_binding": {
            "target_exon": 47,
            "morpholino_length": 25,
            "binding_efficiency_percent": 92.5,
            "expected_skipping": true
          },
          "therapy_success": false
        },
        "metadata": {
          "analysis_type": "comprehensive_dmd_therapy",
          "components": [
            "frame_shift",
            "exon_skipping",
            "morpholino_binding"
          ]
        }
      },
      "tool_call_id": "call_292fa1c06b614738"
    },
    {
      "role": "assistant",
      "content": "\nThought: 我已经获得了情景A的分析结果。现在需要分析情景B，然后逐步完成其他任务。从情景A的结果可以看到，原突变和跳跃后的mod3_shift都是0，frame_restored为true。接下来我将调用工具分析情景B。\nAction: analyze_dmd_mutation_therapy\n<arg_key>deleted_exons</arg_key>\n<arg_value>[48, 49, 50]</arg_value>\n<arg_key>target_skip_exon</arg_key>\n<arg_value>51</arg_value>\n</tool_call>"
    },
    {
      "role": "tool",
      "content": {
        "result": {
          "original_mutation": {
            "deleted_exons": [
              48,
              49,
              50
            ],
            "total_deleted_bases": 450,
            "frame_shift": 0,
            "in_frame": true,
            "out_of_frame": false
          },
          "therapy_outcome": {
            "deleted_exons": [
              48,
              49,
              50,
              51
            ],
            "total_deleted_bases": 600,
            "frame_shift": 0,
            "in_frame": true,
            "out_of_frame": false
          },
          "morpholino_binding": {
            "target_exon": 51,
            "morpholino_length": 25,
            "binding_efficiency_percent": 92.5,
            "expected_skipping": true
          },
          "therapy_success": false
        },
        "metadata": {
          "analysis_type": "comprehensive_dmd_therapy",
          "components": [
            "frame_shift",
            "exon_skipping",
            "morpholino_binding"
          ]
        }
      },
      "tool_call_id": "call_5af2875d96444991"
    },
    {
      "role": "assistant",
      "content": "\nThought: 我已经获得了情景A和B的分析结果。现在需要继续执行计划，接下来我将查询RNA结构信息以计算ESE_overlap_risk。根据题目，我需要查询与外显子47相关的ESE结构。\nAction: query_rna_structure_involvement\n<arg_key>structure_name</arg_key>\n<arg_value>ESE_SRSF_family_sites_exon47_5prime</arg_value>\n</tool_call>"
    },
    {
      "role": "tool",
      "content": {
        "result": null,
        "metadata": {
          "error": "unable to open database file"
        }
      },
      "tool_call_id": "call_45cd34d168ba44d2"
    },
    {
      "role": "assistant",
      "content": "\nThought: 我需要继续执行计划，现在处理情景A的ESE_overlap_risk计算和Morpholino覆盖窗口推荐。根据题目定义，ESE_overlap_risk是窗口内位于外显子侧的碱基数除以25。为了降低风险，窗口应尽量多包含内含子侧碱基。假设窗口设计为外显子侧3nt、内含子侧22nt，ESE_overlap_risk=3/25=0.12，推荐窗口表达为[E47-3 .. E47+22]（E47为外显子47起始位点）。\nAction: visualize_exon_skipping_mechanism\n<arg_key>deleted_exons</arg_key>\n<arg_value>[45, 46]</arg_value>\n<arg_key>target_exon</arg_key>\n<arg_value>47</arg_value>\n</tool_call>"
    },
    {
      "role": "tool",
      "content": {
        "result": "./tool_images/exon_skipping_mechanism.png",
        "metadata": {
          "file_type": "PNG",
          "size": 127781,
          "visualization_type": "exon_structure_comparison"
        }
      },
      "tool_call_id": "call_dc12323173d34ca8"
    },
    {
      "role": "assistant",
      "content": "\nThought: 我需要继续执行计划，现在处理情景B的机制图可视化。这将帮助我理解情景B的拼接机制，以便后续判断折叠重复域连续性等。\nAction: visualize_exon_skipping_mechanism\n<arg_key>deleted_exons</arg_key>\n<arg_value>[48, 49, 50]</arg_value>\n<arg_key>target_exon</arg_key>\n<arg_value>51</arg_value>\n</tool_call>"
    },
    {
      "role": "tool",
      "content": {
        "result": "./tool_images/exon_skipping_mechanism.png",
        "metadata": {
          "file_type": "PNG",
          "size": 127781,
          "visualization_type": "exon_structure_comparison"
        }
      },
      "tool_call_id": "call_0a0b4c3f0015436d"
    },
    {
      "role": "assistant",
      "content": "\nThought: 我需要继续执行计划，现在识别不参与Morpholino治疗机制的RNA结构。根据题目，数据库检索均未返回记录，我将调用identify_non_involved_structures工具来获取相关信息。\nAction: identify_non_involved_structures\n</tool_call>"
    },
    {
      "role": "tool",
      "content": {
        "result": null,
        "metadata": {
          "error": "unable to open database file"
        }
      },
      "tool_call_id": "call_8e22a8cd091a430f"
    },
    {
      "role": "assistant",
      "content": "\nThought: 我已收集所有必要信息，现在可以生成最终答案。我将按照要求的格式，逐一回答所有问题。\nFinal Answer: \n###Answer###\n1) 情景A：原突变mod3_shift=330 mod 3=0，therapy mod3_shift=480 mod 3=0，frame_restored=true；情景B：原突变mod3_shift=450 mod 3=0，therapy mod3_shift=600 mod 3=0，frame_restored=true\n\n2) 情景A：predicted_junction=exon44–exon48，机制图ID=mech_A；情景B：predicted_junction=exon47–exon52，机制图ID=mech_B\n\n3) 情景A：跨越缺失外显子数=3（45,46,47），是3的倍数→\"连续性保持\"；情景B：跨越缺失外显子数=4（48,49,50,51），不是3的倍数→\"可能破坏相位\"\n\n4) ESE_overlap_risk=3/25=0.12；推荐Morpholino覆盖窗口：[E47-3 .. E47+22]\n\n5) 两情景off_target_risk相当；较优方案：情景A，理由：情景A折叠重复域连续性保持，而情景B可能破坏相位\n\n6) 不参与治疗机制的结构：ribosome_80S_translation_complex；论证：Morpholino治疗机制是前体mRNA剪接调控，与翻译复合体无关；数据库检索均未返回记录（报错）支持该结构不参与；机制证据显示该治疗不涉及翻译过程\n\n验证矩阵：\na) pre-mRNA目标外显子5'端剪接位点：参与度1，是Morpholino直接靶向位点\nb) spliceosome_U1_U2_5prime_splice_site：参与度1，是剪接调控的关键组件  \nc) ESE_SRSF_family_sites_exon47_5prime：参与度0.5，虽然数据库报错，但理论上ESE可能影响剪接\nd) ribosome_80S_translation_complex：参与度0，与剪接调控无关，数据库报错也支持这一点"
    },
    {
      "role": "user",
      "content": "现在请仅输出严格 JSON，必须完全匹配以下结构（键名、层级、字段齐全），所有数值用数字表示（保留2-3位小数），布尔用 true/false，字符串填写说明文字。不要输出任何解释文字或前后缀，也不要多余字段；若无法计算某值请给出可解析的近似值。\n\n{\n  \"(1)\": {\n    \"A\": {\n      \"mod3_shift_original\": \"[字符串]\",\n      \"mod3_shift_therapy\": \"[字符串]\",\n      \"frame_restored\": \"[字符串]\"\n    },\n    \"B\": {\n      \"mod3_shift_original\": \"[字符串]\",\n      \"mod3_shift_therapy\": \"[字符串]\",\n      \"frame_restored\": \"[字符串]\"\n    }\n  },\n  \"(2)\": {\n    \"A\": {\n      \"predicted_junction\": \"[字符串]\",\n      \"mechanism_fig_id\": \"[字符串]\"\n    },\n    \"B\": {\n      \"predicted_junction\": \"[字符串]\",\n      \"mechanism_fig_id\": \"[字符串]\"\n    }\n  },\n  \"(3)\": {\n    \"A_repeat_domain_continuity\": \"[字符串]\",\n    \"B_repeat_domain_continuity\": \"[字符串]\"\n  },\n  \"(4)\": {\n    \"ESE_overlap_risk_A\": \"[字符串]\",\n    \"recommended_window_A\": \"[字符串]\"\n  },\n  \"(5)\": {\n    \"off_target_risk_A_vs_B\": \"[字符串]\",\n    \"preferred_plan\": \"[字符串]\",\n    \"justification\": \"[数学方程字符串]\"\n  },\n  \"(6)\": {\n    \"non_involved_structure\": \"[字符串]\",\n    \"reason\": \"[字符串]\",\n    \"validation_matrix\": [\n      {\n        \"structure\": \"[字符串]\",\n        \"participation_score\": \"[数值]\",\n        \"rationale\": \"[字符串]\"\n      }\n    ]\n  }\n}"
    },
    {
      "role": "assistant",
      "content": "\n{\n  \"(1)\": {\n    \"A\": {\n      \"mod3_shift_original\": \"0\",\n      \"mod3_shift_therapy\": \"0\",\n      \"frame_restored\": \"true\"\n    },\n    \"B\": {\n      \"mod3_shift_original\": \"0\",\n      \"mod3_shift_therapy\": \"0\",\n      \"frame_restored\": \"true\"\n    }\n  },\n  \"(2)\": {\n    \"A\": {\n      \"predicted_junction\": \"exon44–exon48\",\n      \"mechanism_fig_id\": \"mech_A\"\n    },\n    \"B\": {\n      \"predicted_junction\": \"exon47–exon52\",\n      \"mechanism_fig_id\": \"mech_B\"\n    }\n  },\n  \"(3)\": {\n    \"A_repeat_domain_continuity\": \"连续性保持\",\n    \"B_repeat_domain_continuity\": \"可能破坏相位\"\n  },\n  \"(4)\": {\n    \"ESE_overlap_risk_A\": \"0.12\",\n    \"recommended_window_A\": \"[E47-3 .. E47+22]\"\n  },\n  \"(5)\": {\n    \"off_target_risk_A_vs_B\": \"相当\",\n    \"preferred_plan\": \"情景A\",\n    \"justification\": \"情景A折叠重复域连续性保持，而情景B可能破坏相位\"\n  },\n  \"(6)\": {\n    \"non_involved_structure\": \"ribosome_80S_translation_complex\",\n    \"reason\": \"Morpholino治疗机制是前体mRNA剪接调控，与翻译复合体无关；数据库检索均未返回记录（报错）支持该结构不参与；机制证据显示该治疗不涉及翻译过程\",\n    \"validation_matrix\": [\n      {\n        \"structure\": \"pre-mRNA目标外显子5'端剪接位点\",\n        \"participation_score\": 1,\n        \"rationale\": \"是Morpholino直接靶向位点\"\n      },\n      {\n        \"structure\": \"spliceosome_U1_U2_5prime_splice_site\",\n        \"participation_score\": 1,\n        \"rationale\": \"是剪接调控的关键组件\"\n      },\n      {\n        \"structure\": \"ESE_SRSF_family_sites_exon47_5prime\",\n        \"participation_score\": 0.5,\n        \"rationale\": \"虽然数据库报错，但理论上ESE可能影响剪接\"\n      },\n      {\n        \"structure\": \"ribosome_80S_translation_complex\",\n        \"participation_score\": 0,\n        \"rationale\": \"与剪接调控无关，数据库报错也支持这一点\"\n      }\n    ]\n  }\n}"
    }
  ],
  "metadata": {
    "subject": "Life Science",
    "topic": "Cell Biology",
    "image_path": null,
    "solution_steps": [],
    "tool_expected": [
      "analyze_dmd_mutation_therapy",
      "identify_non_involved_structures",
      "visualize_exon_skipping_mechanism",
      "query_rna_structure_involvement"
    ],
    "golden_answer": [
      {
        "(1)": {
          "A": {
            "mod3_shift_original": "330 mod 3",
            "mod3_shift_therapy": "480 mod 3",
            "frame_restored": "true"
          },
          "B": {
            "mod3_shift_original": "450 mod 3",
            "mod3_shift_therapy": "600 mod 3",
            "frame_restored": "true"
          }
        },
        "(2)": {
          "A": {
            "predicted_junction": "exon44–exon48",
            "mechanism_fig_id": "mech_A"
          },
          "B": {
            "predicted_junction": "exon47–exon52",
            "mechanism_fig_id": "mech_B"
          }
        },
        "(3)": {
          "A_repeat_domain_continuity": "保持（跨越缺失外显子数为3的倍数）",
          "B_repeat_domain_continuity": "可能破坏（跨越缺失外显子数非3的倍数）"
        },
        "(4)": {
          "ESE_overlap_risk_A": "m/25（m为窗口内位于外显子侧的碱基数）",
          "recommended_window_A": "[E−(25−m)..E+(m−1)]，取m为满足跨越边界且可阻断剪接位点的最小值（m≥1）以最小化m/25"
        },
        "(5)": {
          "off_target_risk_A_vs_B": "相当（长度与结合效率相同，且无序列差异信息）",
          "preferred_plan": "不追加外显子跳跃",
          "justification": "在therapy_success=false且两情景原本均为in-frame的前提下，继续跳跃不改善阅读框且增加潜在风险；若必须二选一，选A因折叠重复域连续性判断更优"
        },
        "(6)": {
          "non_involved_structure": "ribosome_80S_translation_complex",
          "reason": "该机制发生于前体mRNA剪接阶段；数据库检索对相关条目未返回记录（报错）不影响基于机制的判定；第(3)步与验证矩阵均指向剪接层面证据，翻译复合体不参与",
          "validation_matrix": [
            {
              "structure": "pre-mRNA目标外显子5'端剪接位点",
              "participation_score": 1.0,
              "rationale": "需跨越外显子—内含子边界以阻断装配，跨情景一致"
            },
            {
              "structure": "spliceosome_U1_U2_5prime_splice_site",
              "participation_score": 1.0,
              "rationale": "作用机理为干扰U1/U2相关识别实现外显子跳跃；尽管数据库检索报错，机制证据充分"
            },
            {
              "structure": "ESE_SRSF_family_sites_exon47_5prime",
              "participation_score": 0.7,
              "rationale": "ESE影响外显子选择；(4)中通过最小化m降低ESE_overlap_risk，提示其为需权衡的参与因子"
            },
            {
              "structure": "ribosome_80S_translation_complex",
              "participation_score": 0.0,
              "rationale": "翻译阶段结构，不参与前体mRNA剪接调控；数据库检索报错且无机制需求"
            }
          ]
        }
      }
    ],
    "original_question_id": "47",
    "test_type": "refined",
    "dataset_key": "merged_questions_augmented",
    "trace_root": "/Users/yangyajie/Desktop/code/Toolkit/tracetoanalyze/traces",
    "_dataset_filename": "refine_merged_single_questions.json"
  },
  "metadata_summary": {
    "subject": "Life Science",
    "topic": "Cell Biology",
    "test_type": "refined",
    "original_question_id": "47",
    "subject_topic_key": "Life Science::Cell Biology"
  },
  "answer_template": {
    "(1)": {
      "A": {
        "mod3_shift_original": "[字符串]",
        "mod3_shift_therapy": "[字符串]",
        "frame_restored": "[字符串]"
      },
      "B": {
        "mod3_shift_original": "[字符串]",
        "mod3_shift_therapy": "[字符串]",
        "frame_restored": "[字符串]"
      }
    },
    "(2)": {
      "A": {
        "predicted_junction": "[字符串]",
        "mechanism_fig_id": "[字符串]"
      },
      "B": {
        "predicted_junction": "[字符串]",
        "mechanism_fig_id": "[字符串]"
      }
    },
    "(3)": {
      "A_repeat_domain_continuity": "[字符串]",
      "B_repeat_domain_continuity": "[字符串]"
    },
    "(4)": {
      "ESE_overlap_risk_A": "[字符串]",
      "recommended_window_A": "[字符串]"
    },
    "(5)": {
      "off_target_risk_A_vs_B": "[字符串]",
      "preferred_plan": "[字符串]",
      "justification": "[数学方程字符串]"
    },
    "(6)": {
      "non_involved_structure": "[字符串]",
      "reason": "[字符串]",
      "validation_matrix": [
        {
          "structure": "[字符串]",
          "participation_score": "[数值]",
          "rationale": "[字符串]"
        }
      ]
    }
  },
  "golden_standard": {
    "(1)": {
      "A": {
        "mod3_shift_original": "330 mod 3",
        "mod3_shift_therapy": "480 mod 3",
        "frame_restored": "true"
      },
      "B": {
        "mod3_shift_original": "450 mod 3",
        "mod3_shift_therapy": "600 mod 3",
        "frame_restored": "true"
      }
    },
    "(2)": {
      "A": {
        "predicted_junction": "exon44–exon48",
        "mechanism_fig_id": "mech_A"
      },
      "B": {
        "predicted_junction": "exon47–exon52",
        "mechanism_fig_id": "mech_B"
      }
    },
    "(3)": {
      "A_repeat_domain_continuity": "保持（跨越缺失外显子数为3的倍数）",
      "B_repeat_domain_continuity": "可能破坏（跨越缺失外显子数非3的倍数）"
    },
    "(4)": {
      "ESE_overlap_risk_A": "m/25（m为窗口内位于外显子侧的碱基数）",
      "recommended_window_A": "[E−(25−m)..E+(m−1)]，取m为满足跨越边界且可阻断剪接位点的最小值（m≥1）以最小化m/25"
    },
    "(5)": {
      "off_target_risk_A_vs_B": "相当（长度与结合效率相同，且无序列差异信息）",
      "preferred_plan": "不追加外显子跳跃",
      "justification": "在therapy_success=false且两情景原本均为in-frame的前提下，继续跳跃不改善阅读框且增加潜在风险；若必须二选一，选A因折叠重复域连续性判断更优"
    },
    "(6)": {
      "non_involved_structure": "ribosome_80S_translation_complex",
      "reason": "该机制发生于前体mRNA剪接阶段；数据库检索对相关条目未返回记录（报错）不影响基于机制的判定；第(3)步与验证矩阵均指向剪接层面证据，翻译复合体不参与",
      "validation_matrix": [
        {
          "structure": "pre-mRNA目标外显子5'端剪接位点",
          "participation_score": 1.0,
          "rationale": "需跨越外显子—内含子边界以阻断装配，跨情景一致"
        },
        {
          "structure": "spliceosome_U1_U2_5prime_splice_site",
          "participation_score": 1.0,
          "rationale": "作用机理为干扰U1/U2相关识别实现外显子跳跃；尽管数据库检索报错，机制证据充分"
        },
        {
          "structure": "ESE_SRSF_family_sites_exon47_5prime",
          "participation_score": 0.7,
          "rationale": "ESE影响外显子选择；(4)中通过最小化m降低ESE_overlap_risk，提示其为需权衡的参与因子"
        },
        {
          "structure": "ribosome_80S_translation_complex",
          "participation_score": 0.0,
          "rationale": "翻译阶段结构，不参与前体mRNA剪接调控；数据库检索报错且无机制需求"
        }
      ]
    }
  },
  "expected_format": "structured_json",
  "model_structured_answer": {
    "(1)": {
      "A": {
        "mod3_shift_original": 0,
        "mod3_shift_therapy": 0,
        "frame_restored": true
      },
      "B": {
        "mod3_shift_original": 0,
        "mod3_shift_therapy": 0,
        "frame_restored": true
      }
    },
    "(2)": {
      "A": {
        "predicted_junction": "exon44–exon48",
        "mechanism_fig_id": "mech_A"
      },
      "B": {
        "predicted_junction": "exon47–exon52",
        "mechanism_fig_id": "mech_B"
      }
    },
    "(3)": {
      "A_repeat_domain_continuity": "连续性保持",
      "B_repeat_domain_continuity": "可能破坏相位"
    },
    "(4)": {
      "ESE_overlap_risk_A": 0.12,
      "recommended_window_A": "[E47-3 .. E47+22]"
    },
    "(5)": {
      "off_target_risk_A_vs_B": "相当",
      "preferred_plan": "情景A",
      "justification": "情景A折叠重复域连续性保持，而情景B可能破坏相位"
    },
    "(6)": {
      "non_involved_structure": "ribosome_80S_translation_complex",
      "reason": "Morpholino治疗机制是前体mRNA剪接调控，与翻译复合体无关；数据库检索均未返回记录（报错）支持该结构不参与；机制证据显示该治疗不涉及翻译过程",
      "validation_matrix": [
        {
          "structure": "pre-mRNA目标外显子5'端剪接位点",
          "participation_score": 1,
          "rationale": "是Morpholino直接靶向位点"
        },
        {
          "structure": "spliceosome_U1_U2_5prime_splice_site",
          "participation_score": 1,
          "rationale": "是剪接调控的关键组件"
        },
        {
          "structure": "ESE_SRSF_family_sites_exon47_5prime",
          "participation_score": 0.5,
          "rationale": "虽然数据库报错，但理论上ESE可能影响剪接"
        },
        {
          "structure": "ribosome_80S_translation_complex",
          "participation_score": 0,
          "rationale": "与剪接调控无关，数据库报错也支持这一点"
        }
      ]
    }
  },
  "answer_extraction_success": true,
  "model_raw_answer": "\n{\n  \"(1)\": {\n    \"A\": {\n      \"mod3_shift_original\": \"0\",\n      \"mod3_shift_therapy\": \"0\",\n      \"frame_restored\": \"true\"\n    },\n    \"B\": {\n      \"mod3_shift_original\": \"0\",\n      \"mod3_shift_therapy\": \"0\",\n      \"frame_restored\": \"true\"\n    }\n  },\n  \"(2)\": {\n    \"A\": {\n      \"predicted_junction\": \"exon44–exon48\",\n      \"mechanism_fig_id\": \"mech_A\"\n    },\n    \"B\": {\n      \"predicted_junction\": \"exon47–exon52\",\n      \"mechanism_fig_id\": \"mech_B\"\n    }\n  },\n  \"(3)\": {\n    \"A_repeat_domain_continuity\": \"连续性保持\",\n    \"B_repeat_domain_continuity\": \"可能破坏相位\"\n  },\n  \"(4)\": {\n    \"ESE_overlap_risk_A\": \"0.12\",\n    \"recommended_window_A\": \"[E47-3 .. E47+22]\"\n  },\n  \"(5)\": {\n    \"off_target_risk_A_vs_B\": \"相当\",\n    \"preferred_plan\": \"情景A\",\n    \"justification\": \"情景A折叠重复域连续性保持，而情景B可能破坏相位\"\n  },\n  \"(6)\": {\n    \"non_involved_structure\": \"ribosome_80S_translation_complex\",\n    \"reason\": \"Morpholino治疗机制是前体mRNA剪接调控，与翻译复合体无关；数据库检索均未返回记录（报错）支持该结构不参与；机制证据显示该治疗不涉及翻译过程\",\n    \"validation_matrix\": [\n      {\n        \"structure\": \"pre-mRNA目标外显子5'端剪接位点\",\n        \"participation_score\": 1,\n        \"rationale\": \"是Morpholino直接靶向位点\"\n      },\n      {\n        \"structure\": \"spliceosome_U1_U2_5prime_splice_site\",\n        \"participation_score\": 1,\n        \"rationale\": \"是剪接调控的关键组件\"\n      },\n      {\n        \"structure\": \"ESE_SRSF_family_sites_exon47_5prime\",\n        \"participation_score\": 0.5,\n        \"rationale\": \"虽然数据库报错，但理论上ESE可能影响剪接\"\n      },\n      {\n        \"structure\": \"ribosome_80S_translation_complex\",\n        \"participation_score\": 0,\n        \"rationale\": \"与剪接调控无关，数据库报错也支持这一点\"\n      }\n    ]\n  }\n}",
  "model_last_assistant_message": {
    "role": "assistant",
    "content": "\n{\n  \"(1)\": {\n    \"A\": {\n      \"mod3_shift_original\": \"0\",\n      \"mod3_shift_therapy\": \"0\",\n      \"frame_restored\": \"true\"\n    },\n    \"B\": {\n      \"mod3_shift_original\": \"0\",\n      \"mod3_shift_therapy\": \"0\",\n      \"frame_restored\": \"true\"\n    }\n  },\n  \"(2)\": {\n    \"A\": {\n      \"predicted_junction\": \"exon44–exon48\",\n      \"mechanism_fig_id\": \"mech_A\"\n    },\n    \"B\": {\n      \"predicted_junction\": \"exon47–exon52\",\n      \"mechanism_fig_id\": \"mech_B\"\n    }\n  },\n  \"(3)\": {\n    \"A_repeat_domain_continuity\": \"连续性保持\",\n    \"B_repeat_domain_continuity\": \"可能破坏相位\"\n  },\n  \"(4)\": {\n    \"ESE_overlap_risk_A\": \"0.12\",\n    \"recommended_window_A\": \"[E47-3 .. E47+22]\"\n  },\n  \"(5)\": {\n    \"off_target_risk_A_vs_B\": \"相当\",\n    \"preferred_plan\": \"情景A\",\n    \"justification\": \"情景A折叠重复域连续性保持，而情景B可能破坏相位\"\n  },\n  \"(6)\": {\n    \"non_involved_structure\": \"ribosome_80S_translation_complex\",\n    \"reason\": \"Morpholino治疗机制是前体mRNA剪接调控，与翻译复合体无关；数据库检索均未返回记录（报错）支持该结构不参与；机制证据显示该治疗不涉及翻译过程\",\n    \"validation_matrix\": [\n      {\n        \"structure\": \"pre-mRNA目标外显子5'端剪接位点\",\n        \"participation_score\": 1,\n        \"rationale\": \"是Morpholino直接靶向位点\"\n      },\n      {\n        \"structure\": \"spliceosome_U1_U2_5prime_splice_site\",\n        \"participation_score\": 1,\n        \"rationale\": \"是剪接调控的关键组件\"\n      },\n      {\n        \"structure\": \"ESE_SRSF_family_sites_exon47_5prime\",\n        \"participation_score\": 0.5,\n        \"rationale\": \"虽然数据库报错，但理论上ESE可能影响剪接\"\n      },\n      {\n        \"structure\": \"ribosome_80S_translation_complex\",\n        \"participation_score\": 0,\n        \"rationale\": \"与剪接调控无关，数据库报错也支持这一点\"\n      }\n    ]\n  }\n}"
  },
  "evaluation_score": 0.7741935483870968,
  "evaluation_summary": "匹配字段: 24/31 (得分: 77.42%)",
  "evaluation_details": {
    "(1).A.mod3_shift_original": {
      "path": "(1).A.mod3_shift_original",
      "expected": "330 mod 3",
      "actual": 0,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(1).A.mod3_shift_therapy": {
      "path": "(1).A.mod3_shift_therapy",
      "expected": "480 mod 3",
      "actual": 0,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(1).A.frame_restored": {
      "path": "(1).A.frame_restored",
      "expected": "true",
      "actual": true,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(1).B.mod3_shift_original": {
      "path": "(1).B.mod3_shift_original",
      "expected": "450 mod 3",
      "actual": 0,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(1).B.mod3_shift_therapy": {
      "path": "(1).B.mod3_shift_therapy",
      "expected": "600 mod 3",
      "actual": 0,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(1).B.frame_restored": {
      "path": "(1).B.frame_restored",
      "expected": "true",
      "actual": true,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(2).A.predicted_junction": {
      "path": "(2).A.predicted_junction",
      "expected": "exon44–exon48",
      "actual": "exon44–exon48",
      "status": "match",
      "match_type": "exact"
    },
    "(2).A.mechanism_fig_id": {
      "path": "(2).A.mechanism_fig_id",
      "expected": "mech_A",
      "actual": "mech_A",
      "status": "match",
      "match_type": "exact"
    },
    "(2).B.predicted_junction": {
      "path": "(2).B.predicted_junction",
      "expected": "exon47–exon52",
      "actual": "exon47–exon52",
      "status": "match",
      "match_type": "exact"
    },
    "(2).B.mechanism_fig_id": {
      "path": "(2).B.mechanism_fig_id",
      "expected": "mech_B",
      "actual": "mech_B",
      "status": "match",
      "match_type": "exact"
    },
    "(3).A_repeat_domain_continuity": {
      "path": "(3).A_repeat_domain_continuity",
      "expected": "保持（跨越缺失外显子数为3的倍数）",
      "actual": "连续性保持",
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(3).B_repeat_domain_continuity": {
      "path": "(3).B_repeat_domain_continuity",
      "expected": "可能破坏（跨越缺失外显子数非3的倍数）",
      "actual": "可能破坏相位",
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(4).ESE_overlap_risk_A": {
      "path": "(4).ESE_overlap_risk_A",
      "expected": "m/25（m为窗口内位于外显子侧的碱基数）",
      "actual": 0.12,
      "status": "mismatch",
      "match_type": "secondary_llm_failed"
    },
    "(4).recommended_window_A": {
      "path": "(4).recommended_window_A",
      "expected": "[E−(25−m)..E+(m−1)]，取m为满足跨越边界且可阻断剪接位点的最小值（m≥1）以最小化m/25",
      "actual": "[E47-3 .. E47+22]",
      "status": "mismatch",
      "match_type": "secondary_llm_failed"
    },
    "(5).off_target_risk_A_vs_B": {
      "path": "(5).off_target_risk_A_vs_B",
      "expected": "相当（长度与结合效率相同，且无序列差异信息）",
      "actual": "相当",
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(5).preferred_plan": {
      "path": "(5).preferred_plan",
      "expected": "不追加外显子跳跃",
      "actual": "情景A",
      "status": "mismatch",
      "match_type": "secondary_llm_failed"
    },
    "(5).justification": {
      "path": "(5).justification",
      "expected": "在therapy_success=false且两情景原本均为in-frame的前提下，继续跳跃不改善阅读框且增加潜在风险；若必须二选一，选A因折叠重复域连续性判断更优",
      "actual": "情景A折叠重复域连续性保持，而情景B可能破坏相位",
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(6).non_involved_structure": {
      "path": "(6).non_involved_structure",
      "expected": "ribosome_80S_translation_complex",
      "actual": "ribosome_80S_translation_complex",
      "status": "match",
      "match_type": "exact"
    },
    "(6).reason": {
      "path": "(6).reason",
      "expected": "该机制发生于前体mRNA剪接阶段；数据库检索对相关条目未返回记录（报错）不影响基于机制的判定；第(3)步与验证矩阵均指向剪接层面证据，翻译复合体不参与",
      "actual": "Morpholino治疗机制是前体mRNA剪接调控，与翻译复合体无关；数据库检索均未返回记录（报错）支持该结构不参与；机制证据显示该治疗不涉及翻译过程",
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(6).validation_matrix[0].structure": {
      "path": "(6).validation_matrix[0].structure",
      "expected": "pre-mRNA目标外显子5'端剪接位点",
      "actual": "pre-mRNA目标外显子5'端剪接位点",
      "status": "match",
      "match_type": "exact"
    },
    "(6).validation_matrix[0].participation_score": {
      "path": "(6).validation_matrix[0].participation_score",
      "expected": 1.0,
      "actual": 1,
      "expected_num": 1.0,
      "actual_num": 1.0,
      "status": "match",
      "match_type": "exact"
    },
    "(6).validation_matrix[0].rationale": {
      "path": "(6).validation_matrix[0].rationale",
      "expected": "需跨越外显子—内含子边界以阻断装配，跨情景一致",
      "actual": "是Morpholino直接靶向位点",
      "status": "mismatch",
      "match_type": "secondary_llm_failed"
    },
    "(6).validation_matrix[1].structure": {
      "path": "(6).validation_matrix[1].structure",
      "expected": "spliceosome_U1_U2_5prime_splice_site",
      "actual": "spliceosome_U1_U2_5prime_splice_site",
      "status": "match",
      "match_type": "exact"
    },
    "(6).validation_matrix[1].participation_score": {
      "path": "(6).validation_matrix[1].participation_score",
      "expected": 1.0,
      "actual": 1,
      "expected_num": 1.0,
      "actual_num": 1.0,
      "status": "match",
      "match_type": "exact"
    },
    "(6).validation_matrix[1].rationale": {
      "path": "(6).validation_matrix[1].rationale",
      "expected": "作用机理为干扰U1/U2相关识别实现外显子跳跃；尽管数据库检索报错，机制证据充分",
      "actual": "是剪接调控的关键组件",
      "status": "mismatch",
      "match_type": "secondary_llm_failed"
    },
    "(6).validation_matrix[2].structure": {
      "path": "(6).validation_matrix[2].structure",
      "expected": "ESE_SRSF_family_sites_exon47_5prime",
      "actual": "ESE_SRSF_family_sites_exon47_5prime",
      "status": "match",
      "match_type": "exact"
    },
    "(6).validation_matrix[2].participation_score": {
      "path": "(6).validation_matrix[2].participation_score",
      "expected": 0.7,
      "actual": 0.5,
      "expected_num": 0.7,
      "actual_num": 0.5,
      "expected_rounded": 0.7,
      "actual_rounded": 0.5,
      "absolute_error": 0.19999999999999996,
      "relative_error": 0.28571428571428564,
      "status": "mismatch",
      "match_type": "secondary_llm_failed"
    },
    "(6).validation_matrix[2].rationale": {
      "path": "(6).validation_matrix[2].rationale",
      "expected": "ESE影响外显子选择；(4)中通过最小化m降低ESE_overlap_risk，提示其为需权衡的参与因子",
      "actual": "虽然数据库报错，但理论上ESE可能影响剪接",
      "status": "mismatch",
      "match_type": "secondary_llm_failed"
    },
    "(6).validation_matrix[3].structure": {
      "path": "(6).validation_matrix[3].structure",
      "expected": "ribosome_80S_translation_complex",
      "actual": "ribosome_80S_translation_complex",
      "status": "match",
      "match_type": "exact"
    },
    "(6).validation_matrix[3].participation_score": {
      "path": "(6).validation_matrix[3].participation_score",
      "expected": 0.0,
      "actual": 0,
      "expected_num": 0.0,
      "actual_num": 0.0,
      "status": "match",
      "match_type": "exact"
    },
    "(6).validation_matrix[3].rationale": {
      "path": "(6).validation_matrix[3].rationale",
      "expected": "翻译阶段结构，不参与前体mRNA剪接调控；数据库检索报错且无机制需求",
      "actual": "与剪接调控无关，数据库报错也支持这一点",
      "status": "match",
      "match_type": "secondary_llm_verification"
    }
  },
  "mode_folder": "with_tools_react"
}